AzTrials
AzTrials

Sustained Selective AttentionTefflonNCT01831167

Effect of Dynamic Light Application on Performance of ICU Nurses

A study testing dynamic light in people with Sustained Selective Attention and Divided Attention, run by Jeroen Bosch Ziekenhuis at 2 sites in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In two sessions of four days nurses will be exposed to dynamic lighting and normal (reference) lighting. Through the psychological tests T.O.D.A. (Test or divided attention) and T.O.S.S.A. (Test of sustained selective attention), then the focus tested. These two tests run both 5 times. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
dynamic light
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
2 sitesNetherlands
Study dates
Jan 2013to Apr 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

ICU nurses working 32 hours/week or more

Trial locations and contacts

2 sites in 1 country.

Netherlands2 sites
  • Jeroen Bosch Ziekenhuis

    's-Hertogenbosch, 5200ME

  • Jeroen Bosch Ziekenhuis

    's-Hertogenbosch

Other trials in Netherlands

About this study

In two sessions of four days nurses will be exposed to dynamic lighting and normal (reference) lighting. Through the psychological tests T.O.D.A. (Test or divided attention) and T.O.S.S.A. (Test of sustained selective attention), then the focus tested. These two tests run both 5 times. The investigators also ask to fill out: 3 questionnaires, fatigue and mood, sleep and Questions of Life.

Being tested
dynamic light
Keywords
dynamic light application, sustained attention, divided attention, nursing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • dynamic lightOther

Study groups in NCT01831167
Study groupRoleWhat they receive
dynamic lightExperimentaldynamic light
Receives: Other: dynamic light
referenceNo interventionnormal light

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. score on Test of Divided Attention

    divided attention

    Measured: march 2013

  2. Test on Sustained Selective Attention(TOSSA)

    Measured: to april 2013

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2013 (estimated)
  2. Study startJan 2013
  3. Primary completionApr 2013
  4. Study completionApr 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01831167
Sponsor's protocol ID
IC-JBZ-Tefflon
Acronym
Tefflon
Status last verified
Apr 2013
First submitted
4 Apr 2013
Last updated
15 Apr 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing dynamic light in people with Sustained Selective Attention and Divided Attention, run by Jeroen Bosch Ziekenhuis at 2 sites in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Apr 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

score on Test of Divided Attention (time frame: march 2013). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in